275 related articles for article (PubMed ID: 10481551)
1. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].
Stepień A
Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551
[TBL] [Abstract][Full Text] [Related]
2. Serotonin receptors and the acute attack of migraine.
Goadsby PJ
Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053
[TBL] [Abstract][Full Text] [Related]
3. Migraine management. New approaches focus on serotonin receptors.
DeRaps PK
Adv Nurse Pract; 1999 May; 7(5):51-5. PubMed ID: 10578735
[No Abstract] [Full Text] [Related]
4. Present and future of 5-HT receptor agonists as antimigraine drugs.
Pauwels PJ; John GW
Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
[TBL] [Abstract][Full Text] [Related]
5. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
Kato K
No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861
[No Abstract] [Full Text] [Related]
6. 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
Peroutka SJ
Neurology; 1993 Jun; 43(6 Suppl 3):S34-8. PubMed ID: 8389009
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic windows.
Mol Interv; 2010 Apr; 10(2):69-71. PubMed ID: 20368365
[No Abstract] [Full Text] [Related]
8. [Physiopathology of migraine].
Pascual J; Castro ME
Neurologia; 1998 Jan; 13(1):29-32. PubMed ID: 9522580
[No Abstract] [Full Text] [Related]
9. [Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses].
Hamon M; Bourgoin S
Pathol Biol (Paris); 2000 Sep; 48(7):619-29. PubMed ID: 11072640
[TBL] [Abstract][Full Text] [Related]
10. The way to serotonergic use and abuse in migraine.
Nicolodi M; Del Bianco PL; Sicuteri F
Int J Clin Pharmacol Res; 1997; 17(2-3):79-84. PubMed ID: 9403359
[TBL] [Abstract][Full Text] [Related]
11. [New triptanes in control of migraine attacks. More rapid onset of action--more efficient reduction of pain].
MMW Fortschr Med; 2002 Jan; 144(3-4):52-3. PubMed ID: 11862794
[No Abstract] [Full Text] [Related]
12. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
13. Current concepts of migraine and its treatment.
Dahlöf CG
Neurologia; 1999 Feb; 14(2):67-77. PubMed ID: 10100422
[No Abstract] [Full Text] [Related]
14. Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.
MacLeod AM; Street LJ; Reeve AJ; Jelley RA; Sternfeld F; Beer MS; Stanton JA; Watt AP; Rathbone D; Matassa VG
J Med Chem; 1997 Oct; 40(22):3501-3. PubMed ID: 9357515
[No Abstract] [Full Text] [Related]
15. Headache.
Vijayan N
West J Med; 1995 Nov; 163(5):474-5. PubMed ID: 8533416
[No Abstract] [Full Text] [Related]
16. [Stabilization treatments of migraine].
Regli F; Nater B; Dworak N
Praxis (Bern 1994); 1995 Sep; 84(38):1032-5. PubMed ID: 7481301
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan--a new treatment of migraine.
Neighbor ML
West J Med; 1993 Nov; 159(5):597-8. PubMed ID: 8279161
[No Abstract] [Full Text] [Related]
18. Are the triptans for migraine therapy worth the cost?
Becker WJ
Can J Neurol Sci; 2000 May; 27(2):111-5. PubMed ID: 10830342
[TBL] [Abstract][Full Text] [Related]
19. The discovery and development of the triptans, a major therapeutic breakthrough.
Humphrey PP
Headache; 2008 May; 48(5):685-7. PubMed ID: 18471110
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the use of triptans in acute migraine.
Pham B
Can J Neurol Sci; 2001 Aug; 28(3):272. PubMed ID: 11513349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
